AU4927390A - Fusion proteins - Google Patents

Fusion proteins

Info

Publication number
AU4927390A
AU4927390A AU49273/90A AU4927390A AU4927390A AU 4927390 A AU4927390 A AU 4927390A AU 49273/90 A AU49273/90 A AU 49273/90A AU 4927390 A AU4927390 A AU 4927390A AU 4927390 A AU4927390 A AU 4927390A
Authority
AU
Australia
Prior art keywords
fusion proteins
fusion
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU49273/90A
Other versions
AU642859B2 (en
Inventor
Anthony Robin Carroll
Berwyn Ewart Clarke
Peter Edmund Highfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU4927390A publication Critical patent/AU4927390A/en
Application granted granted Critical
Publication of AU642859B2 publication Critical patent/AU642859B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU49273/90A 1987-02-10 1990-02-08 Fusion proteins Ceased AU642859B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1294887A 1987-02-10 1987-02-10
US012948 1987-02-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU69792/87A Division AU596154B2 (en) 1987-02-10 1987-03-06 Fusion proteins

Publications (2)

Publication Number Publication Date
AU4927390A true AU4927390A (en) 1990-08-09
AU642859B2 AU642859B2 (en) 1993-11-04

Family

ID=21757520

Family Applications (2)

Application Number Title Priority Date Filing Date
AU69792/87A Ceased AU596154B2 (en) 1987-02-10 1987-03-06 Fusion proteins
AU49273/90A Ceased AU642859B2 (en) 1987-02-10 1990-02-08 Fusion proteins

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU69792/87A Ceased AU596154B2 (en) 1987-02-10 1987-03-06 Fusion proteins

Country Status (4)

Country Link
JP (1) JPS63196299A (en)
AU (2) AU596154B2 (en)
CA (1) CA1319628C (en)
NZ (1) NZ219516A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626183B2 (en) * 1989-09-19 1992-07-23 Wellcome Foundation Limited, The Chimaeric hepadnavirus core antigen proteins
WO1999007839A2 (en) * 1997-08-05 1999-02-18 Vlaams Interuniversitair Instituut Voor Biotechnologie Immunoprotective influenza antigen and its use in vaccination
US7731972B1 (en) 2000-02-04 2010-06-08 Vlaams Interuniversitair Instituut Voor Biotechnologie Immunoprotective influenza antigen and its use in vaccination
US8420102B2 (en) 2006-03-07 2013-04-16 Vaxinnate Corporation Compositions that include hemagglutinin
US8574588B2 (en) 2005-01-19 2013-11-05 VanInnate Corporation Fusion proteins comprising flagellin and dengue viral envelope proteins
US8647634B2 (en) 2008-12-25 2014-02-11 The Chemo-Sero-Therapeutic Research Institute Recombinant avian infectious coryza vaccine and process for preparing same
US8932598B2 (en) 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use
US8932605B2 (en) 2008-04-18 2015-01-13 Vaxinnate Corporation Deletion mutants of flagellin and methods of use

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468050C (en) * 1991-03-15 1998-02-11 Pharmacia & Upjohn Ab Recombinant human factor VIII derivative
WO1993006126A1 (en) * 1991-09-13 1993-04-01 Chiron Corporation Immunoreactive hepatitis c virus polypeptide compositions
US10548973B2 (en) * 2015-08-25 2020-02-04 Xiamen University Polypeptide carrier for presenting target polypeptide and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
AU572108B2 (en) * 1983-01-19 1988-05-05 Genentech Inc. Human tpa production using vectors coding for dhfr protein
EP0175261B1 (en) * 1984-09-12 1991-12-11 Chiron Corporation Hybrid particle immunogens
JPS6274295A (en) * 1985-09-25 1987-04-06 チロン　コ−ポレイシヨン Hybrid granular immunogen
NZ219515A (en) * 1987-02-10 1989-09-27 Wellcome Found Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626183B2 (en) * 1989-09-19 1992-07-23 Wellcome Foundation Limited, The Chimaeric hepadnavirus core antigen proteins
WO1999007839A2 (en) * 1997-08-05 1999-02-18 Vlaams Interuniversitair Instituut Voor Biotechnologie Immunoprotective influenza antigen and its use in vaccination
WO1999007839A3 (en) * 1997-08-05 1999-05-14 Vlaams Interuniv Inst Biotech Immunoprotective influenza antigen and its use in vaccination
US7732130B2 (en) 1997-08-05 2010-06-08 Vlaams Interuniversitair Instituut Voor Biotechnolgoie Immunoprotective influenza antigen and its use in vaccination
US7993652B2 (en) 1997-08-05 2011-08-09 FVlaams Interuniversitair Instituut Voors Biotechnologie Immunoprotective influenza antigen and its use in vaccination
US7731972B1 (en) 2000-02-04 2010-06-08 Vlaams Interuniversitair Instituut Voor Biotechnologie Immunoprotective influenza antigen and its use in vaccination
US9446115B2 (en) 2005-01-19 2016-09-20 Vaxinnate Corporation Methods of stimulating immunity employing dengue viral antigens
US8574588B2 (en) 2005-01-19 2013-11-05 VanInnate Corporation Fusion proteins comprising flagellin and dengue viral envelope proteins
US9234009B2 (en) 2005-01-19 2016-01-12 Vaxinnate Corporation Methods of stimulating protective immunity employing Dengue viral antigens
US8871221B2 (en) 2005-01-19 2014-10-28 Vaxinnate Corporation Methods of stimulating protective immunity employing Dengue viral antigens
US8945579B2 (en) 2006-03-07 2015-02-03 Vaxinnate Corporation Methods of treatment with compositions that include hemagglutinin
US9056901B2 (en) 2006-03-07 2015-06-16 Vaxinnate Corporation Methods of making hemagglutinin proteins
US8420102B2 (en) 2006-03-07 2013-04-16 Vaxinnate Corporation Compositions that include hemagglutinin
US8932605B2 (en) 2008-04-18 2015-01-13 Vaxinnate Corporation Deletion mutants of flagellin and methods of use
US9205138B2 (en) 2008-04-18 2015-12-08 Vaxinnate Corporation Deletion mutants of flagellin and methods of use
US9211320B2 (en) 2008-04-18 2015-12-15 Vaxinnate Corporation Deletion mutants of flagellin and methods of use
US8647634B2 (en) 2008-12-25 2014-02-11 The Chemo-Sero-Therapeutic Research Institute Recombinant avian infectious coryza vaccine and process for preparing same
US8932598B2 (en) 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use

Also Published As

Publication number Publication date
JPS63196299A (en) 1988-08-15
CA1319628C (en) 1993-06-29
AU596154B2 (en) 1990-04-26
NZ219516A (en) 1991-02-26
AU642859B2 (en) 1993-11-04
AU6979287A (en) 1988-08-11

Similar Documents

Publication Publication Date Title
AU1480388A (en) Altered antibodies
AU4382193A (en) BPI-immunoglobulin fusion proteins
AU5142485A (en) Cytotoxic protein
AU1072988A (en) Anticoagulant peptides
AU1664688A (en) Thiadiazinones
AU1466188A (en) Bifunctional proteins
AU2414288A (en) Polypeptide compounds
AU1381888A (en) Timeswitches
AU626147B2 (en) Fibrinolytic proteins
AU1301788A (en) Chemo-radio-immuno-conjugates
AU1388788A (en) Pivot joint
AU1263488A (en) Pivot joint
AU6979287A (en) Fusion proteins
AU1180088A (en) Protein extracts
AU625634B2 (en) Pivot joint
AU3804589A (en) Novel proteins
AU1533288A (en) Pivot joint
AU1590788A (en) Leukaemia-inhibitory factor
AU2081788A (en) Novel thrombolytic proteins
AU1313888A (en) Pivot joint
AU1158888A (en) Scraper-spreader
AU1366388A (en) Videosystem
AU3804689A (en) Modified proteins
AU591298B2 (en) Improved fusion method
AU7451587A (en) Improved fusion products